Particle.news

Wise Group Faces U.S. Securities Suit Over Alleged Concealment of AML Failures

Who becomes lead plaintiff will decide who runs the case and shape prospects for investor recoveries and further regulator action.

Overview

  • A securities class action was filed in the U.S. District Court for the Southern District of New York seeking damages for investors who bought Wise Group plc (NASDAQ: WSE) between May 11, 2026 and July 23, 2026.
  • The complaint alleges Wise and certain senior executives misled investors about anti‑money‑laundering and counter‑terrorist‑financing controls and downplayed regulatory risk when the company moved its primary listing to Nasdaq on May 11, 2026.
  • Reuters reported on June 1 that Brussels prosecutors were probing Wise Europe over transactions reportedly involving more than €500 million, a disclosure the complaint says triggered a multi‑day share decline.
  • The Wall Street Journal reported on July 24 that the Office of the Comptroller of the Currency denied Wise’s U.S. trust charter, citing long‑standing AML and CTF deficiencies, and the shares fell again after that report.
  • Multiple plaintiff firms have issued competing notices seeking appointment as lead plaintiff with differing court deadlines reported for September 28 and September 29, 2026, and the case remains at the pre‑certification stage with allegations unproven.